Side-effects associated with ketamine use in depression: a systematic review
Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K. | The Lancet Psychiatry | 27 July 2017
LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark
Larsen, J. K. | Nordic Journal of Psychiatry | 5 July 2017
A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum
Li, S., Cheng, X., & Wang, C. | Journal of Ethnopharmacology | 5 May 2017
Modern Clinical Research on LSD
Liechti, M. E. | Neuropsychopharmacology | 27 April 2017
Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action
Andrade, C. | The Journal of clinical psychiatry | 1 April 2017
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., ... & Nemeroff, C. B. | Jama psychiatry | 1 April 2017
Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults
Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., ... & Hutson, P. R. | Clinical Pharmacokinetics | 28 March 2017
Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
Kiraly, D. D., Horn, S. R., Van Dam, N. T., Costi, S., Schwartz, J., Kim-Schulze, S., ... & Iosifescu, D. V. | Translational psychiatry | 21 March 2017
LSD instead of 25I-NBOMe: The revival of LSD? A case report
Bodeau, S., Bennis, Y., Régnaut, O., Fabresse, N., Richeval, C., Humbert, L., ... & Lemaire-Hurtel, A. S. | Toxicologie Analytique et Clinique | 27 February 2017
Ayahuasca dimethyltryptamine, and psychosis: a systematic review of human studies
dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | Therapeutic Advances in Psychopharmacology | 23 February 2017
Safety pharmacology of acute MDMA administration in healthy subjects
Vizeli, P., & Liechti, M. E. | Journal of Psychopharmacology | 21 February 2017
Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects
Vizeli, P., Schmid, Y., Prestin, K., zu Schwabedissen, H. E. M., & Liechti, M. E. | European Neuropsychopharmacology | 20 January 2017
Tackling Harm Reduction, Human Rights and Drug Uses on Recreational Environments: Tensions, Potentialities and Learnings from the Kosmicare Project (Portugal)
Soares, M., Carvalho, M. C., Valbom, M., & Rodrigues, T. | Revista Crítica de Ciências Sociais | 16 January 2017
Ecstasy research: will increasing observational data aid our understanding of MDMA?
Amoroso, T. | The Lancet Psychiatry | 1 December 2016
Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats
Noworyta-Sokołowska, K., Kamińska, K., Kreiner, G., Rogóż, Z., & Gołembiowska, K. | Neurotoxicity research | 30 November 2016
Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015
Heise, C. W., & Brooks, D. E. | Journal of medical toxicology | 28 November 2016
Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant
Zhu, W., Ding, Z., Zhang, Y., Shi, J., Hashimoto, K., & Lu, L. | Neuroscience Bulletin | 22 November 2016
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
Barrett, F. S., Bradstreet, M. P., Leoutsakos, J. M. S., Johnson, M. W., & Griffiths, R. R. | Journal of Psychopharmacology | 17 November 2016
Decision-making in chronic ecstasy users: a systematic review
Betzler, F., Viohl, L., & Romanczuk‐Seiferth, N. | European Journal of Neuroscience | 15 November 2016
Cognitive and behavioural effects induced by social stress plus MDMA administration in mice
García-Pardo, M. P., Roger-Sánchez, C., Rodríguez-Arias, M., Miñarro, J., & Aguilar, M. A. | Behavioural Brain Research | 10 November 2016
A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4 Methylendioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction
Darracq, M. A., Thornton, S. L., Minns, A. B., & Gerona, R. R. | Journal of Psychoactive Drugs | 16 September 2016
Ayahuasca Treatment Center Safety for the Western Seeker
Ray, R. R., & Lassiter, K. S. | Anthropology of Consciousness | 15 September 2016
Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review
Romeo, B., Choucha, W., Fossati, P., & Rotge, J. Y. | L'Encephale | 9 September 2016
Multisystem Organ Failure and Death Resulting From Ingestion of “Molly” (3,4-Methylenedioxymethamphetamine)
Shelton, C. P., & Rosini, J. M. | Journal of Emergency Nursing | 1 September 2015
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R. | Journal of Psychopharmacology | 30 August 2016